project id: TCGA-LUAD; case submitter id: TCGA-69-8453; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; rna integrity number: 8.1; age at index: 77; days to birth: -28413; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1935; age at diagnosis: 28413; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 813.0; icd 10 code: C34.30; last known disease status: not reported; morphology: 8480/3; primary diagnosis: Mucinous adenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 0.6575342465753424; pack years smoked: 12.0; is ffpe: false; weight: 38.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.4; longest dimension: 0.6; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-69-8453-01A-12; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 2.0; percent stromal cells: 9.0; percent tumor cells: 89.0; percent tumor nuclei: 70.0;